2013
DOI: 10.1073/pnas.1314289110
|View full text |Cite
|
Sign up to set email alerts
|

Rewriting the rules for end joining via enzymatic splicing of DNA 3′-PO 4 and 5′-OH ends

Abstract: There are many biological contexts in which DNA damage generates "dirty" breaks with 3′-PO 4 (or cyclic-PO 4 ) and 5′-OH ends that cannot be sealed by DNA ligases. Here we show that the Escherichia coli RNA ligase RtcB can splice these dirty DNA ends via a unique chemical mechanism. RtcB transfers GMP from a covalent RtcB-GMP intermediate to a DNA 3′-PO 4 to form a "capped" 3′ end structure, DNA 3′ pp 5′ G. When a suitable DNA 5′-OH end is available, RtcB catalyzes attack of the 5′-OH on DNA 3′ pp 5′ G to form… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
42
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 31 publications
(46 citation statements)
references
References 22 publications
3
42
0
Order By: Relevance
“…Since then, our laboratory has improved the purification of recombinant RtcB protein, such that it is fully dependent on exogenous GTP for sealing activity (5). Moreover, we have developed new substrates to assay the cyclic phosphodiesterase (CPDase), 3=-PO 4 /5=-OH ligation, 3=-PO 4 guanylylation, and 3=-ppG/5=-OH ligation reactions under single-turnover conditions (5)(6)(7)(8). Here we applied these interval technical advances to reexamine the effects of active-site alanine mutations on E. coli RtcB function in vitro.…”
Section: Figmentioning
confidence: 99%
See 2 more Smart Citations
“…Since then, our laboratory has improved the purification of recombinant RtcB protein, such that it is fully dependent on exogenous GTP for sealing activity (5). Moreover, we have developed new substrates to assay the cyclic phosphodiesterase (CPDase), 3=-PO 4 /5=-OH ligation, 3=-PO 4 guanylylation, and 3=-ppG/5=-OH ligation reactions under single-turnover conditions (5)(6)(7)(8). Here we applied these interval technical advances to reexamine the effects of active-site alanine mutations on E. coli RtcB function in vitro.…”
Section: Figmentioning
confidence: 99%
“…2). The predominance of "soft" metal ligands (histidine nitrogens and cysteine sulfur) in the active site explains the observed metal activity and inhibition spectrum of E. coli RtcB (1,5,8), whereby (i) the overall ligation pathway and the component steps of RtcB guanylylation and phosphodiester synthesis rely on Mn 2ϩ , which is favorably coordinated by soft ligands; (ii) "hard" metals Mg 2ϩ and Ca 2ϩ , which favor oxygen ligands, neither support RtcB activity themselves nor inhibit RtcB function in the presence of Mn 2ϩ ; and (iii) alternative soft metals Zn 2ϩ , Co 2ϩ , Cu 2ϩ , and Ni 2ϩ that do not support activity are potent inhibitors of activity in the presence of Mn 2ϩ , presumably because they compete with Mn 2ϩ for binding to one or both metal sites, whence bound they are unable to sustain catalysis. It is an open question whether both Mn 2ϩ sites in the binuclear cluster are required for each step in the RtcB pathway or if some of the steps rely on just one of the metal ions.…”
mentioning
confidence: 96%
See 1 more Smart Citation
“…A simple way to address this issue is to query whether any or all of the nucleotides of a spliceable polynucleotide substrate for AtRNL (exclusive of the 3 ′ nucleotide) can be replaced by deoxynucleotides. This approach has been fruitful in delineating the minimal RNA content required for other RNA repair enzymes, including T4 RNA ligase 2 (Nandakumar and Shuman 2004), the RNA terminal 2 ′ -O-methyltransferase Hen1 (Jain and Shuman 2011), the RNA 3 ′ -terminal cyclase RtcA (Das and Shuman 2013), and the RNA 3 ′ -PO 4 /5 ′ -OH ligase RtcB (Das et al 2013a). Here, we tested whether AtRNL could splice a HO D17R>p substrate, consisting of 17 deoxynucleotides and a single 32 Plabeled 3 ′ -terminal ribonucleoside-2 ′ ,3 ′ -cyclic-PO 4 (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…We also analyze the kinetics and substrate requirements of an exemplary fungal tRNA ligase, Kluyveromyces lactis Trl1 (KlaTrl1). Fungal Trl1 enzymes are potential therapeutic targets, because their structures and biochemical mechanisms are unique compared to the RtcB-type tRNA repair systems elaborated by metazoans, archaea, and many bacteria (Popow et al 2011;Chakravarty et al 2012;Englert et al 2012;Das et al 2013a;Desai et al 2013). Indeed, mammalian proteomes have no discernable homologs of the sealing domain of fungal tRNA ligase.…”
Section: Introductionmentioning
confidence: 99%